Peter Virsik
Chief Operating Officer at ESSA PHARMA INC.
Net worth: 101 371 $ as of 2024-03-30
Profile
Peter A.
Virsik is currently the Chief Operating Officer & Executive Vice President at ESSA Pharma, Inc. He previously worked as an Associate Director at Gilead Sciences, Inc. from 2000 to 2005 and as the Senior Vice President-Corporate Development at XenoPort, Inc. from 2005 to 2015.
Virsik received his undergraduate degree from the University of California, Berkeley, his graduate degree from the University of Michigan, and his MBA from Kellogg School of Management.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ESSA PHARMA INC
0.03% | 2024-04-04 | 11,940 ( 0.03% ) | 101 371 $ | 2024-03-30 |
Peter Virsik active positions
| Companies | Position | Start |
|---|---|---|
| ESSA PHARMA INC. | Chief Operating Officer | 2016-07-31 |
Former positions of Peter Virsik
| Companies | Position | End |
|---|---|---|
| XENOPORT, INC. | Corporate Officer/Principal | 2014-12-31 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 2004-12-31 |
Training of Peter Virsik
| University of California, Berkeley | Undergraduate Degree |
| University of Michigan | Graduate Degree |
| Kellogg School of Management | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| ESSA PHARMA INC. | Health Technology |
| Private companies | 1 |
|---|---|
XenoPort, Inc.
 XenoPort, Inc. Pharmaceuticals: MajorHealth Technology XenoPort, Inc. operated as a biopharmaceutical company. Its products included horizant and regnite. The company was founded by Ronald W. Barrett, William J. Dower and Mark A. Gallop on December 17, 1999 and was headquartered in Atlanta, GA. | Health Technology |
- Stock Market
- Insiders
- Peter Virsik
